JP2008528446A5 - - Google Patents

Download PDF

Info

Publication number
JP2008528446A5
JP2008528446A5 JP2007549559A JP2007549559A JP2008528446A5 JP 2008528446 A5 JP2008528446 A5 JP 2008528446A5 JP 2007549559 A JP2007549559 A JP 2007549559A JP 2007549559 A JP2007549559 A JP 2007549559A JP 2008528446 A5 JP2008528446 A5 JP 2008528446A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
component
nanoparticles
composition according
chitosan
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2007549559A
Other languages
English (en)
Japanese (ja)
Other versions
JP5384831B2 (ja
JP2008528446A (ja
Filing date
Publication date
Priority claimed from US11/029,082 external-priority patent/US7265090B2/en
Priority claimed from US11/284,734 external-priority patent/US7282194B2/en
Application filed filed Critical
Publication of JP2008528446A publication Critical patent/JP2008528446A/ja
Publication of JP2008528446A5 publication Critical patent/JP2008528446A5/ja
Application granted granted Critical
Publication of JP5384831B2 publication Critical patent/JP5384831B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2007549559A 2005-01-04 2005-12-27 タンパク質ドラッグデリバリ用ナノ粒子 Expired - Fee Related JP5384831B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US11/029,082 2005-01-04
US11/029,082 US7265090B2 (en) 2004-10-05 2005-01-04 Nanoparticles for paracellular drug delivery
US11/284,734 US7282194B2 (en) 2004-10-05 2005-11-21 Nanoparticles for protein drug delivery
US11/284,734 2005-11-21
PCT/US2005/047125 WO2006073950A2 (en) 2005-01-04 2005-12-27 Nanoparticles for protein drug delivery

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2013112996A Division JP2013177434A (ja) 2005-01-04 2013-05-29 タンパク質ドラッグデリバリ用ナノ粒子

Publications (3)

Publication Number Publication Date
JP2008528446A JP2008528446A (ja) 2008-07-31
JP2008528446A5 true JP2008528446A5 (https=) 2009-02-12
JP5384831B2 JP5384831B2 (ja) 2014-01-08

Family

ID=36648027

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2007549559A Expired - Fee Related JP5384831B2 (ja) 2005-01-04 2005-12-27 タンパク質ドラッグデリバリ用ナノ粒子
JP2013112996A Pending JP2013177434A (ja) 2005-01-04 2013-05-29 タンパク質ドラッグデリバリ用ナノ粒子

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2013112996A Pending JP2013177434A (ja) 2005-01-04 2013-05-29 タンパク質ドラッグデリバリ用ナノ粒子

Country Status (8)

Country Link
US (4) US7282194B2 (https=)
EP (1) EP1833470A4 (https=)
JP (2) JP5384831B2 (https=)
CN (1) CN101360486B (https=)
AU (1) AU2005322940B2 (https=)
BR (1) BRPI0518093A (https=)
CA (1) CA2592991C (https=)
WO (1) WO2006073950A2 (https=)

Families Citing this family (82)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7282194B2 (en) * 2004-10-05 2007-10-16 Gp Medical, Inc. Nanoparticles for protein drug delivery
US7901711B1 (en) * 2006-04-17 2011-03-08 Gp Medical, Inc. Nanoparticles for protein/peptide delivery and delivery means thereof
US8137697B1 (en) * 2004-10-05 2012-03-20 Gp Medical, Inc. Nanoparticles for protein/peptide delivery and delivery means thereof
US7879361B2 (en) * 2005-01-04 2011-02-01 Gp Medical, Inc. Nanoparticles for drug delivery
US7541028B2 (en) * 2005-01-04 2009-06-02 Gp Medical, Inc. Nanoparticles for monoclonal antibody delivery
EP1774971A1 (en) * 2005-10-14 2007-04-18 Advanced in Vitro Cell Technologies, S.L. Chitosan and heparin nanoparticles
US8097245B2 (en) 2005-12-28 2012-01-17 Advanced Bionutrition Corporation Delivery vehicle for probiotic bacteria comprising a dry matrix of polysaccharides, saccharides and polyols in a glass form and methods of making same
US8968721B2 (en) 2005-12-28 2015-03-03 Advanced Bionutrition Corporation Delivery vehicle for probiotic bacteria comprising a dry matrix of polysaccharides, saccharides and polyols in a glass form and methods of making same
EP1991111B1 (en) * 2006-02-27 2011-04-06 Edwards Lifesciences Corporation Hydrogel for an intravenous amperometric biosensor
JP2007291324A (ja) * 2006-03-31 2007-11-08 Jsr Corp 酸化物微粒子含有ポリシロキサン組成物およびその製造方法
JP2007270056A (ja) * 2006-03-31 2007-10-18 Jsr Corp 金属酸化物微粒子含有ポリシロキサン組成物およびその製造方法
US8449915B1 (en) * 2006-04-17 2013-05-28 Gp Medical, Inc. Pharmaceutical composition of nanoparticles
WO2008002568A2 (en) * 2006-06-26 2008-01-03 Mutual Pharmaceutical Company, Inc. Active agent formulations, methods of making, and methods of use
US20080160096A1 (en) * 2006-07-27 2008-07-03 Janos Berbely Polymeric nanoparticles by ion-ion interactions
CN101148511B (zh) * 2006-09-18 2010-10-20 中国科学院过程工程研究所 荧光壳聚糖微球的制备方法及其在示踪剂领域的应用
US8946200B2 (en) * 2006-11-02 2015-02-03 Southwest Research Institute Pharmaceutically active nanosuspensions
US8460726B2 (en) * 2006-12-18 2013-06-11 Advanced Bionutrition Corporation Dry food product containing live probiotic
US20080193547A1 (en) * 2006-12-27 2008-08-14 Janos Borbely Polymeric nanoparticles by ion-ion Interactions
PT2155255E (pt) * 2007-05-09 2013-10-15 Nitto Denko Corp Composições que incluem um composto hidrofóbico e um conjugado de poliaminoácido
WO2009035438A1 (en) * 2007-09-13 2009-03-19 Janos Borbely Polymeric nanoparticles by ion-ion interactions
WO2009065181A1 (en) * 2007-11-21 2009-05-28 Apollo Life Sciences Limited Nanostructures suitable for delivery of agents
IL188647A0 (en) * 2008-01-08 2008-11-03 Orina Gribova Adaptable structured drug and supplements administration system (for oral and/or transdermal applications)
US8404850B2 (en) * 2008-03-13 2013-03-26 Southwest Research Institute Bis-quaternary pyridinium-aldoxime salts and treatment of exposure to cholinesterase inhibitors
EP2296637B1 (en) * 2008-04-24 2014-04-02 Medtronic, Inc Chitosan-containing protective composition
CN102216381B (zh) 2008-04-24 2016-06-15 麦德托尼克公司 可再水化的多糖颗粒和海绵体
EP2310002B1 (en) 2008-04-24 2016-11-02 Medtronic, Inc Protective gel based on chitosan and oxidized polysaccharide
WO2009132226A1 (en) * 2008-04-24 2009-10-29 Medtronic, Inc. Thiolated chitosan gel
WO2009132224A2 (en) * 2008-04-24 2009-10-29 Medtronic, Inc. Rehydratable thiolated polysaccharide particles and sponge
JP5841708B2 (ja) * 2008-07-01 2016-01-13 日東電工株式会社 表面被覆微粒子の医薬組成物
US8722706B2 (en) * 2008-08-15 2014-05-13 Southwest Research Institute Two phase bioactive formulations of bis-quaternary pyridinium oxime sulfonate salts
US20100104608A1 (en) * 2008-09-26 2010-04-29 Tyco Healthcare Group Lp Reactive surgical implant
US8241654B2 (en) * 2008-09-26 2012-08-14 Tyco Healthcare Group Lp Reactive surgical implant
US8309134B2 (en) * 2008-10-03 2012-11-13 Southwest Research Institute Modified calcium phosphate nanoparticle formation
US20100111919A1 (en) * 2008-10-31 2010-05-06 Tyco Healthcare Group Lp Delayed gelation compositions and methods of use
JP2010132609A (ja) * 2008-12-05 2010-06-17 Fujifilm Corp カゼインナノ粒子
US20100159010A1 (en) * 2008-12-24 2010-06-24 Mutual Pharmaceutical Company, Inc. Active Agent Formulations, Methods of Making, and Methods of Use
WO2010087781A1 (en) * 2009-01-28 2010-08-05 Agency For Science, Technology And Research Polyelectrolyte complexes with bound peptides
WO2010111565A2 (en) 2009-03-27 2010-09-30 Advanced Bionutrition Corporation Microparticulated vaccines for the oral or nasal vaccination and boostering of animals including fish
WO2010138522A2 (en) 2009-05-26 2010-12-02 Advanced Bionutrition Corporation Stable dry powder composition comprising biologically active microorganisms and/or bioactive materials and methods of making
US8404281B2 (en) * 2009-06-08 2013-03-26 Avant Garde Therapeutics & Technologies Llc Formulations
EP2446899B1 (en) * 2009-06-25 2020-09-30 Bioleaders Corporation Adjuvant composition comprising (poly-gamma-glutamate)-chitosan nanoparticles
CA2767342C (en) 2009-07-09 2018-05-01 Oshadi Drug Administration Ltd. Matrix carrier compositions, methods and uses
US8637096B2 (en) 2009-12-04 2014-01-28 Curtis C. Stojan Compositions and method for enhancing insulin activity
US9504750B2 (en) 2010-01-28 2016-11-29 Advanced Bionutrition Corporation Stabilizing composition for biological materials
US8834951B2 (en) 2010-01-28 2014-09-16 Advanced Bionutrition Corporation Dry glassy composition comprising a bioactive material
US9028873B2 (en) * 2010-02-08 2015-05-12 Southwest Research Institute Nanoparticles for drug delivery to the central nervous system
US8592364B2 (en) * 2010-02-11 2013-11-26 Ecole Polytechnique Federale de Lausanne (“EPFL”) CCR7 ligand delivery and co-delivery in immunotherapy
JP2011178764A (ja) * 2010-03-04 2011-09-15 Ajinomoto Co Inc 腸内ビフィズス菌増殖促進剤および腸管バリア機能改善剤
EP2417968A1 (en) 2010-07-29 2012-02-15 Consorzio per il Centro di Biomedicina Molecolare Scrl Particle comprising cytokines, antibodies and polymers and use thereof as medicament for the treatment of cancer
WO2012021783A2 (en) 2010-08-13 2012-02-16 Advanced Bionutrition Corporation Dry storage stabilizing composition for biological materials
US10285943B2 (en) 2010-12-02 2019-05-14 Greenmark Biomedical Inc. Aptamer bioconjugate drug delivery device
WO2013081720A1 (en) * 2011-12-02 2013-06-06 Ecosynthetix Ltd. Aptamer bioconjugate drug delivery device
US9713702B2 (en) * 2011-03-14 2017-07-25 The Board Of Trustee Of The Leland Stanford Junior University Methods of electric field induced delivery of compounds, compositions used in delivery, and systems of delivery
WO2012170017A1 (en) * 2011-06-08 2012-12-13 Avant Garde Therapeutics Inc. Novel formulations
US9505852B2 (en) 2011-06-13 2016-11-29 Rival, Société En Commandite N,N,N-trialkylaminopolymers, methods of their preparation and uses thereof
JP5801626B2 (ja) * 2011-06-30 2015-10-28 国立大学法人信州大学 複合ナノ繊維の製造方法
US8883717B2 (en) * 2012-03-30 2014-11-11 Artificial Cell Technologies, Inc. Antigenic compositions and methods
US10555911B2 (en) 2012-05-04 2020-02-11 Yale University Highly penetrative nanocarriers for treatment of CNS disease
US8313774B1 (en) 2012-06-26 2012-11-20 Magnifica Inc. Oral solid composition
US11504422B2 (en) 2013-01-09 2022-11-22 National Cheng Kung University Biodegradable nanocomplex
TWI511744B (zh) * 2013-01-09 2015-12-11 Univ Nat Cheng Kung 可任意調整介面電荷與粒徑大小之生物可分解載體、其製備方法及含彼之醫藥組合物
WO2015032971A1 (en) * 2013-09-09 2015-03-12 Lek Pharmaceuticals D.D. Polymer selection for preparation of nps with high protein loading
EP3052091B1 (en) 2013-10-01 2019-04-24 Lifecare Innovations Pvt. Ltd. Sustained release formulations containing methylglyoxal and their therapeutic applications
EP3065782B8 (en) 2013-11-05 2021-05-26 Elena Molokanova Nanostructure conjugates for modulation of location-specific subtypes of receptors and ion channels
CN103656623B (zh) * 2013-12-06 2015-04-15 南通大学 载有神经营养因子的纳米微球及制备和用途
US11039621B2 (en) 2014-02-19 2021-06-22 Corning Incorporated Antimicrobial glass compositions, glasses and polymeric articles incorporating the same
US9622483B2 (en) 2014-02-19 2017-04-18 Corning Incorporated Antimicrobial glass compositions, glasses and polymeric articles incorporating the same
US11039620B2 (en) 2014-02-19 2021-06-22 Corning Incorporated Antimicrobial glass compositions, glasses and polymeric articles incorporating the same
EP3142645A4 (en) 2014-05-15 2017-12-27 Rani Therapeutics, LLC Pharmaceutical compositions and methods for fabrication of solid masses comprising polypeptides and/or proteins
US11548940B2 (en) 2014-05-15 2023-01-10 Rani Therapeutics, Llc Anti-interleukin antibody preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
US20170304374A1 (en) * 2014-10-23 2017-10-26 Symbiotic Health Inc. Capsule for the oral administration of biopharmaceuticals
AU2016257813B2 (en) * 2015-05-01 2021-05-13 Rani Therapeutics, Llc Pharmaceutical compositions and methods for fabrication of solid masses comprising polypeptides and/or proteins
JP6889699B2 (ja) 2015-07-29 2021-06-18 アドバンスド バイオニュートリション コープ． 特定栄養用途のための安定乾燥プロバイオティクス組成物
US12558395B2 (en) 2015-07-29 2026-02-24 Advanced Bionutrition Corp. Stable dry probiotic compositions for special dietary uses
KR101882820B1 (ko) 2015-12-30 2018-07-30 주식회사 삼양바이오팜 점막부착성 약학 조성물 및 그의 제조방법
US11491114B2 (en) 2016-10-12 2022-11-08 Curioralrx, Llc Formulations for enteric delivery of therapeutic agents
US20230190665A1 (en) * 2017-01-19 2023-06-22 The Johns Hopkins University Therapeutic protein-loaded nanoparticle and method for preparing the same
CN107651664B (zh) * 2017-10-16 2020-11-06 浙江领蔚生物技术有限公司 一种荧光碳纳米粒子及用作细胞标记材料的用途
CA3090303A1 (en) 2018-03-28 2019-10-03 Greenmark Biomedical Inc. Phosphate crosslinked starch nanoparticle and dental treatments
US20240315972A1 (en) 2021-07-12 2024-09-26 Zidkiyahu Simenhaus Protein containing bio-active compositions comprising cellulose microparticle carriers
CN114470186B (zh) * 2022-02-17 2023-10-20 唐颐控股(深圳)有限公司 一种可吸入式纳米新冠疫苗的制备方法
KR20250144708A (ko) * 2024-03-27 2025-10-13 한국과학기술연구원 올리고감마글루탐산 유도체 기반의 신규한 지질 및 이를 포함하는 지질나노입자와 이의 용도

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE167396T1 (de) 1993-02-22 1998-07-15 Alza Corp Mittel zur oralen gabe von wirkstoffen
US5510118A (en) 1995-02-14 1996-04-23 Nanosystems Llc Process for preparing therapeutic compositions containing nanoparticles
IE80468B1 (en) 1995-04-04 1998-07-29 Elan Corp Plc Controlled release biodegradable nanoparticles containing insulin
US5962019A (en) 1995-08-25 1999-10-05 Sangstat Medical Corporation Oral cyclosporin formulations
PT986404E (pt) * 1996-07-10 2002-09-30 West Pharm Serv Drug Res Ltd Sistema de entrega de terapia genica com alvo no endotelio
US6933331B2 (en) 1998-05-22 2005-08-23 Nanoproducts Corporation Nanotechnology for drug delivery, contrast agents and biomedical implants
US5972389A (en) 1996-09-19 1999-10-26 Depomed, Inc. Gastric-retentive, oral drug dosage forms for the controlled-release of sparingly soluble drugs and insoluble matter
IE970794A1 (en) 1997-09-24 2000-08-23 Elan Corp Plc Composition and method for enhancing paracellular transport across cell layers
AU9799198A (en) * 1997-10-09 1999-05-03 Vanderbilt University Micro-particulate and nano-particulate polymeric delivery system
US6726934B1 (en) 1997-10-09 2004-04-27 Vanderbilt University Micro-particulate and nano-particulate polymeric delivery system
US6517869B1 (en) 1997-12-12 2003-02-11 Expression Genetics, Inc. Positively charged poly(alpha-(omega-aminoalkyl)lycolic acid) for the delivery of a bioactive agent via tissue and cellular uptake
FR2780901B1 (fr) 1998-07-09 2000-09-29 Coletica Particules, en particulier micro- ou nanoparticules de monosaccharides et oligosaccharides reticules, leurs procedes de preparation et compositions cosmetiques, pharmaceutiques ou alimentaires en contenant
US6632457B1 (en) 1998-08-14 2003-10-14 Incept Llc Composite hydrogel drug delivery systems
AU4476600A (en) * 1999-04-22 2000-11-10 Vanderbilt University Polymeric encapsulation system promoting angiogenesis
KR20020012215A (ko) 1999-05-07 2002-02-15 파르마솔 게엠베하 지질 매트릭스-약물 컨쥬게이트로부터 조제된 활성성분의투여 제어를 위한 약물 운반체
US6645525B1 (en) * 1999-06-23 2003-11-11 Sedum Laboratories, Inc. Ionically formulated biomolecule microcarriers
US6767635B1 (en) * 1999-09-14 2004-07-27 Biomedical Apherese Systeme Gmbh Magnetic nanoparticles having biochemical activity, method for the production thereof and their use
GB0126923D0 (en) 2001-11-09 2002-01-02 Procter & Gamble Chitosan compositions
JP2005514438A (ja) * 2001-12-21 2005-05-19 ソーン， デイビッド エス． 薬剤の可溶化、安定化、及び運搬のためのオリゴマー及びポリマーの使用
GB0302738D0 (en) * 2003-02-06 2003-03-12 Advanced Biopolymers As Composition
ES2226567B1 (es) * 2003-06-20 2006-07-01 Universidad De Santiago De Compostela Nanoparticulas de acido hialuronico.
US7282194B2 (en) * 2004-10-05 2007-10-16 Gp Medical, Inc. Nanoparticles for protein drug delivery
US7265090B2 (en) * 2004-10-05 2007-09-04 Gp Medical, Inc. Nanoparticles for paracellular drug delivery
US7879819B1 (en) * 2005-01-04 2011-02-01 Gp Medical, Inc. Nanoparticles for protein drug delivery
US7611690B2 (en) * 2005-01-04 2009-11-03 Gp Medical, Inc. Nanoparticles for protein drug delivery
US7541046B1 (en) * 2005-01-04 2009-06-02 Gp Medical, Inc. Nanoparticles for protein drug delivery
US7604795B1 (en) * 2005-01-04 2009-10-20 Gp Medical, Inc. Nanoparticles for protein drug delivery
US7541028B2 (en) * 2005-01-04 2009-06-02 Gp Medical, Inc. Nanoparticles for monoclonal antibody delivery
US7291598B2 (en) * 2005-01-04 2007-11-06 Gp Medical, Inc. Nanoparticles for protein drug delivery
US20070148251A1 (en) * 2005-12-22 2007-06-28 Hossainy Syed F A Nanoparticle releasing medical devices

Similar Documents

Publication Publication Date Title
JP2008528446A5 (https=)
WO2006073950B1 (en) Nanoparticles for protein drug delivery
Subramanian et al. Mucus interaction to improve gastrointestinal retention and pharmacokinetics of orally administered nano-drug delivery systems
Wong Chitosan and its use in design of insulin delivery system
CN1993113B (zh) 包含磷酸钙纳米颗粒核心，生物分子和胆汁酸的颗粒，其生产方法，其治疗用途
CN101137700B (zh) 微粒及医药组合物
Ariful Islam et al. Mucoadhesive chitosan derivatives as novel drug carriers
US11471422B2 (en) Stealth, targeted nanoparticles (STN) for oral drug delivery
JP6533232B2 (ja) 親水性活性化合物のナノカプセル化
CN102970864A (zh) 纳米颗粒药物组合物
CN111672018B (zh) 载药医疗器械及制备方法、药物球囊、药物涂层制备方法
Michalak et al. Polymeric nanoparticles–a novel solution for delivery of antimicrobial agents
Ong et al. Nanoparticular and other carriers to deliver lactoferrin for antimicrobial, antibiofilm and bone-regenerating effects: a review
Rafiee et al. An overview of microparticulate drug delivery system and its extensive therapeutic applications in diabetes
Chen et al. Current therapeutic strategy in the nasal delivery of insulin: recent advances and future directions
Carmen Chifiriuc et al. Biomedical applications of natural polymers for drug delivery
KR20180075650A (ko) 고분자량 및 고밀도 코팅을 갖는 점액 침투성 입자
Pal et al. Advances in engineering of low molecular weight hydrogels for chemotherapeutic applications
Lori et al. pH-sensitive polymer-based carriers as a useful approach for oral delivery of therapeutic protein: a review
Parhi Chitin and chitosan in drug delivery
Sharaf et al. Chitin and chitosan applications in medication delivery systems
Das et al. Chitosan-based systems for oral drug delivery applications
US20230293437A1 (en) A pharmaceutical composition in oral dosage form
ES2969208T3 (es) Composiciones de ácido gamma-poliglutámico y zinc
Kriplani et al. Chitosan-a potential polymer to prepare anticancer drug delivery systems: Patent review